August John

5PUBLICATIONS

37CO-AUTHORS

Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 01, 2026

Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.

|Oct 15, 2024

The Role of CENPK Splice Variant in Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer.

Minhong Huang, Sisi Qin, Huanyao Gao

|Jun 19, 2024

Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer.

Esther P B Rodman, Michael J Emch, Xiaonan Hou

|Jan 05, 2023

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.

Shawn H R Lee, Wenjian Yang, Yoshihiro Gocho

|May 29, 2020

Patient-specific multi-omics models and the application in personalized combination therapy.

August John, Bo Qin, Krishna R Kalari

Pageof 1

Frequent Collaborators

Esther P B Rodman

Michael J Emch

Adam D Bass

Gustavo Baldassarre

Scott H Kaufmann

John R Hawse

Jia Yu

Wenjian Yang

Hannah Williams

Kristine R Crews

Frequent Collaborators

Esther P B Rodman

Michael J Emch

Adam D Bass

Gustavo Baldassarre